Professor Suzanne Cory
Australia’s exuberant network of immunologists is delighted to be hosting colleagues from around the world at the 2016 Congress in Melbourne. This is a very exciting period in immunology. Novel genetic and technological approaches are rapidly advancing fundamental understanding of the immune system and providing more effective approaches for conquering traditional and emerging microbial foes. Excitingly, immunotherapy for cancer has come of age and offers great promise. The Melbourne Congress promises to be not only an intellectual feast, but also a vibrant cultural experience. Delegates will also have the opportunity to experience Australia’s unique natural environment. Make sure you do not miss the 2016 International Congress of Immunology in Melbourne!
Professor Peter Doherty
The International Congresses of Immunology provide terrific venues for you to present your science, and to hear great overviews from leading researchers across our discipline. Melbourne 2016 will continue that tradition, with the social plus that the Congress Centre, affordable accommodation and restaurants are in easy, and pleasant walking distance. And, though it will be cooler in Melbourne, winter “down under” is exactly the right time to add a side trip to the spectacular sites in Australia’s hot, deep north. Lock August 21-26 2016 into your calendar now!
Professor Ian Frazer
Immunology research has become increasingly relevant to clinical practice over the last decade, with the ability to manipulate human immune responses in a clinically relevant manner not only to pathogenic organisms, but also to self antigens and to tumours. The early 21st century is truly the dawn of a new era of targeted applied immunology. The 2016 International Immunology congress in Melbourne will bring together basic immunologists with leaders in vaccine development, tumour immunotherapy, and regulation of autoimmune responses, from Australia and round the world. It will give immunologists the chance to show our clinical colleagues how relevant our discipline has become to the common chronic inflammatory, infectious, and neoplastic diseases that comprise so much of the chronic health problems we face today.
Professor Jacques Miller
Fundamental discoveries on thymus and T and B cell functions were followed by an avalanche of work that eventually led to the decoding of signalling molecules and pathways critical for immune responses and their regulation. This set the seeds for targeting interventions based on monoclonal antibodies and genetic engineering. It has led translational researchers to use checkpoint blockade and chimaeric antigen T cell receptors with spectacular success in some clinical conditions, especially cancer. Thus, immunology has spawned immunotherapy and can claim a seat in the therapeutic toolkit of oncology next to, and possibly about to supersede surgery, radiotherapy and chemotherapy.
Sir Gustav Nossal
Following the successful Third International Congress of Immunology in Sydney in 1977, it is a real thrill to provide this brief testimonial in support of the 2016 Congress in Melbourne. Not only does Australia find itself importantly positioned in the Asia-Pacific Region, with its burgeoning research output, but also the occasion serves as a reminder of the excellence of Australian immunology down the decades. Ever since the ground-breaking work of Sir Macfarlane Burnet going back over 60 years, Australia has been in the forefront of most of the major developments in our great discipline. The 2016 Congress will showcase this work and will provide an opportunity for scientists from all over the world to network, including with their Australian colleagues. Preparation for the Congress is proceeding smoothly and meticulously, everyone will be assured of a truly warm welcome in 2016.